(1S,5S)-3-(5,6-Dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent

    公开(公告)号:NZ588123A

    公开(公告)日:2012-04-27

    申请号:NZ58812304

    申请日:2004-05-20

    Applicant: ABBOTT LAB

    Abstract: Disclosed is a pharmaceutical composition for treating amyotrophic lateral sclerosis or premenstrual syndrome which comprises a therapeutically effective amount of (1S,5S)-3-(5,6-dichloro-pyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane or a pharmaceutically acceptable salt thereof. Further disclosed is a pharmaceutical composition comprising a therapeutically effective amount of (1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane or a pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable carrier, wherein the composition is in a solid dosage form or a liquid dosage form. Also disclosed is (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane (L)-tartrate and (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane p-toluenesulfonate.

Patent Agency Ranking